about
Clinical implications of tumor necrosis factor receptor 2 in breast cancer.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Chemotherapy in Premenopausal Breast Cancer Patients
@ast
Chemotherapy in Premenopausal Breast Cancer Patients
@en
Chemotherapy in Premenopausal Breast Cancer Patients
@nl
type
label
Chemotherapy in Premenopausal Breast Cancer Patients
@ast
Chemotherapy in Premenopausal Breast Cancer Patients
@en
Chemotherapy in Premenopausal Breast Cancer Patients
@nl
prefLabel
Chemotherapy in Premenopausal Breast Cancer Patients
@ast
Chemotherapy in Premenopausal Breast Cancer Patients
@en
Chemotherapy in Premenopausal Breast Cancer Patients
@nl
P2860
P356
P1433
P1476
Chemotherapy in Premenopausal Breast Cancer Patients
@en
P2093
Ann H Partridge
P2860
P304
P356
10.1159/000441371
P407
P577
2015-10-01T00:00:00Z